One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

"Goalkeepers" Report About It’s Main Targets, Including HIV

13 September 2017 13:25

The Bill and Melinda Gates Foundation announced the first-annual "Goalkeepers" report — a report about the main targets of the foundation, aimed to improve health care and treatment for the future generations.

HIV is one of the most important areas of the foundation to work on.  According to the actual statistics, published in the buisinessinsider, the HIV rate is   about 0.14 people per 1,000 population, down from a high of 0.30 in the early 2000s. Bill Gates notes, that now people seem feel safe because of many medical developments and progress in HIV treatment over the last decades. Models developed by the Gates Foundation and the Institute for Health Metrics and Evaluation show that a 10% cut in HIV treatment funding could lead to 5.6 million deaths by 2030.

Africa remains in the high risk zone, even with the preservation of HIV funding programs. If  the situation with the medical facilities and health care system remains the same, there is a high risk for more than 250 million people to get HIV-positive status.

"What that means is pretty clear. If we only do as well as we've been doing on prevention, the absolute number of people getting HIV will go up even beyond its previous peak. In the meantime, if we don't spend more to deliver the tools we have now, we'll have more cases. If we have more cases, we'll need to spend more on treatment, or people will die." - Gates comment the release of the foundation.

Latest News

DIY faecal transplants carry risks including HIV and hepatitis

Faecal transplants have been used in medical settings to tackle superbugs, but following YouTube videos at home is too risky, say researchers.

16 February 15:30

Gilead's total revenues were $26.1 billion in 2017

For the fourth quarter 2017, Gilead Sciences total revenues were $5.9 billion. For the full year 2017, total revenues were $26.1 billion. HIV and HBV product sales for the full year 2017 were $14.2 billion. Genvoya represents the most successful HIV launch in the U.S. and ...

16 February 09:31

Key vaginal bacteria identified that increase HIV risk in women

Women's risk of HIV significantly associated with key bacteria and their abundance in the vagina.

15 February 16:35

Experimental Drug Kills Flu Virus in a Single Day

Shionogi developed baloxavir marboxil by leveraging discoveries made in anti-HIV drugs, targeting a different kind of enzyme and preventing cells from susceptibility to virus infection in the first place.

15 February 13:27